Welcome to our dedicated page for Microvision SEC filings (Ticker: MVIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing MicroVision鈥檚 dense discussions of MEMS lasers, lidar calibration, and IP licensing agreements can feel like shining a diode into a fogbank. Each quarterly earnings report details shifting R&D burn rates and prototype milestones, while an 8-K may quietly announce a new OEM lidar evaluation. Missing one disclosure could upend your valuation model.
Stock Titan solves this problem. Our AI turns every MicroVision SEC filing into plain-English insights within seconds, whether you need the latest microvision quarterly earnings report 10-Q filing or a historical microvision annual report 10-K simplified. AG真人官方-time alerts surface microvision Form 4 insider transactions real-time, so you instantly see when executives buy or sell shares. Guided keyword flags highlight ADAS revenue commentary, patent additions, and cash-runway notes, letting you answer natural questions such as 鈥淗ow much is MicroVision spending on lidar R&D this quarter?鈥� without scrolling through hundreds of pages.
Every document type is covered:
- Form 4 for microvision insider trading Form 4 transactions and microvision executive stock transactions Form 4
- 10-Q and AI-driven microvision earnings report filing analysis
- 10-K with section-by-section guidance鈥攊deal for understanding microvision SEC documents with AI
- Proxy statements detailing microvision proxy statement executive compensation
- 8-K updates with microvision 8-K material events explained
Stop hunting through EDGAR tables; let Stock Titan鈥檚 expert summaries, ratio visualizations, and side-by-side quarter comparisons surface the trends that matter鈥攍icensing revenue growth, production-scale readiness, or insider sentiment鈥攕o you can act before the market does.
MicroVision, Inc. (MVIS) director Jada Smith received 22,007 shares when restricted stock units (RSUs) vested on 09/02/2025 and were distributed on a unit-for-share basis without payment. After the distribution, the reporting person beneficially owned 82,344 shares of common stock directly. The Form 4 also discloses RSUs granted 06/06/2025 that vest in four equal quarterly installments through the earlier of the first anniversary of the grant or the day before the 2026 annual meeting, subject to continued service as a director.
MicroVision director Peter Schabert received 22,007 shares when vested restricted stock units converted to common stock on 09/02/2025. The shares were distributed at $0.00 as vested RSUs convert on a unit-for-unit basis without payment. After the transaction Schabert beneficially owned 102,457 shares. The filing corrects an earlier RSU grant reporting error, noting the original Form 4 misreported totals and that the vesting disclosed here was calculated using a stated 鈥渃orrect鈥� RSU amount. The Form 4 was signed by an attorney-in-fact on behalf of Schabert.
Laura J. Peterson, a director of MicroVision, Inc. (MVIS), received 18,006 shares of MicroVision common stock on 09/02/2025 when vested restricted stock units (RSUs) converted to shares on a unit-for-unit basis with no cash payment. After the transaction the reporting person beneficially owns 18,006 shares directly. The Form 4 indicates these shares resulted from RSUs granted on 06/06/2025 that were scheduled to vest in four equal quarterly installments and convert to common stock at vesting.
Jeffrey A. Herbst, a director of MicroVision, Inc. (MVIS), received 22,007 shares of common stock on 09/02/2025 upon vesting of restricted stock units (RSUs). The RSUs converted on a one-for-one basis into common shares at no cash payment, increasing His beneficial ownership to 186,713 shares following the transaction. The filing corrects an earlier grant reporting error: the original Form 4 filed 06/06/2025 misstated the total RSUs granted; the correct total used for vesting calculations is 88,028 RSUs.
This Form 4 reports a routine equity compensation vesting event for a director and does not disclose any sale or cash proceeds. The transaction was reported on 09/03/2025 by an attorney-in-fact signing for the reporting person.
MicroVision, Inc. director Robert Paul Carlile received 22,007 shares of common stock on 09/02/2025 when restricted stock units vested and were distributed on a unit-for-share basis at no cost. After the distribution, Mr. Carlile beneficially owned 306,785 shares of MicroVision common stock. The Form 4 corrects a prior grant reporting error: an earlier filing misreported the total RSUs granted in June 2025, and this filing explains the vesting calculation used for the distributed shares.
MicroVision director Simon Biddiscombe received 22,007 shares of common stock on 09/02/2025 when restricted stock units (RSUs) vested and converted to shares on a unit-for-unit basis with no payment required. After the distribution, the reporting person beneficially owned 247,285 shares. The filing corrects an earlier Form 4 that misstated the total RSUs granted in June 2025; the correct grant amount was 88,028 RSUs, and the vesting here reflects that corrected figure. The transaction was reported by an attorney-in-fact on 09/03/2025.
State Street Corporation reported beneficial ownership of 13,063,945 shares of MicroVision Inc. common stock, equal to 5.2% of the class. The filing shows no sole voting or dispositive power and records shared voting power of 12,776,440 and shared dispositive power of 13,063,945, indicating institutional-level holdings without exclusive control.
The statement lists affiliated investment-adviser subsidiaries that hold the securities, including SSGA Funds Management, State Street Global Advisors Europe Limited and State Street Global Advisors Trust Company. The filer certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.